Proto Script Pharmaceutical Profit Margin

The latest profit margin for PSCR is -1386.22% as of September 2017. That compares with -22.31% in the prior-year period — down 6114.5% year over year. That is below the sector sector average of 13.2%. Investors often review this figure alongside Proto Script Pharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, PSCR's profit margin moved from -22.31% to -1386.22% — a 6114.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Proto Script Pharmaceutical's valuation or profitability profile.

Against its sector companies, PSCR currently prints -1386.22% for profit margin, while the sector average sits near 13.2%. That is roughly 10602.5% below the sector mean. Large gaps often invite a closer look at Proto Script Pharmaceutical's growth, margins, and balance sheet.

Profit Margin shows how effectively Proto Script Pharmaceutical converts resources into returns. At -1386.22%, PSCR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -22.31% in the prior-year period — down 6114.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PSCR's profit margin (-1386.22%), review year-over-year change from -22.31%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.